Eip Pharma

Obsidian Therapeutics Inc, based in Cambridge, MA, is at the forefront of precision cell and gene therapy, utilizing its proprietary cytoDRIVE platform to engineer regulated therapeutic proteins. The company is dedicated to pioneering the next generation of engineered therapeutics to address critical patient needs. With a focus on innovative solutions, Obsidian is advancing its lead clinical program, OBX115, an engineered TIL cell therapy targeting advanced melanoma. The company’s commitment to collaboration and urgency drives its mission to improve patient outcomes through cutting-edge science and technology. Generated from the website

Visterra, Inc. is a biotechnology company based in Waltham, MA, dedicated to bringing better biologics to life. With a strong leadership team and a focus on innovative research, Visterra aims to develop groundbreaking therapies for various medical conditions. Through their comprehensive approach and extensive pipeline of programs, including VIS649 Sibeprenlimab, VIS171, and VIS513, Visterra is committed to advancing the field of biotechnology and improving patient outcomes. Their dedication to clinical trials, particularly in the area of IgA Nephropathy, showcases their commitment to finding effective treatments for challenging diseases.Generated from the website

Proteostasis Therapeutics is a biopharmaceutical company based in Cambridge, MA that focuses on developing novel therapeutics for diseases caused by dysfunctional protein regulation. With a dedicated team of researchers and scientists, the company is committed to advancing drug discovery and development in the field of proteostasis to address unmet medical needs. Generated from their business information